The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/5/1646 |
_version_ | 1797474376721891328 |
---|---|
author | Chiyuki Awahara Daiki Oku Saki Furuta Kazuya Kobayashi Kenta Teruya Kenichi Akaji Yasunao Hattori |
author_facet | Chiyuki Awahara Daiki Oku Saki Furuta Kazuya Kobayashi Kenta Teruya Kenichi Akaji Yasunao Hattori |
author_sort | Chiyuki Awahara |
collection | DOAJ |
description | In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors. |
first_indexed | 2024-03-09T20:29:11Z |
format | Article |
id | doaj.art-729c42ba1efe4d00ae669f19ffbe04f5 |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-03-09T20:29:11Z |
publishDate | 2022-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-729c42ba1efe4d00ae669f19ffbe04f52023-11-23T23:27:39ZengMDPI AGMolecules1420-30492022-03-01275164610.3390/molecules27051646The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 ProteaseChiyuki Awahara0Daiki Oku1Saki Furuta2Kazuya Kobayashi3Kenta Teruya4Kenichi Akaji5Yasunao Hattori6Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Neurochemistry, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8575, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanCenter for Instrumental Analysis, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanIn this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors.https://www.mdpi.com/1420-3049/27/5/1646HTLV-1 proteaseinhibitorretro–inverso conversionhydroxyethylamine isostere |
spellingShingle | Chiyuki Awahara Daiki Oku Saki Furuta Kazuya Kobayashi Kenta Teruya Kenichi Akaji Yasunao Hattori The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease Molecules HTLV-1 protease inhibitor retro–inverso conversion hydroxyethylamine isostere |
title | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_full | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_fullStr | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_full_unstemmed | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_short | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_sort | effects of side chain configurations of a retro inverso type inhibitor on the human t cell leukemia virus htlv 1 protease |
topic | HTLV-1 protease inhibitor retro–inverso conversion hydroxyethylamine isostere |
url | https://www.mdpi.com/1420-3049/27/5/1646 |
work_keys_str_mv | AT chiyukiawahara theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT daikioku theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT sakifuruta theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kazuyakobayashi theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kentateruya theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kenichiakaji theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT yasunaohattori theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT chiyukiawahara effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT daikioku effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT sakifuruta effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kazuyakobayashi effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kentateruya effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kenichiakaji effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT yasunaohattori effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease |